The origin of the virus responsible for the ongoing yellow fever epidemic in Brazil, the worst for 40 years, has just been identified by scientists affiliated with two Brazilian institutions: Adolfo Lutz Institute (IAL) and the University of São Paulo (USP).
Indwelling devices like catheters cause roughly 25 percent of hospital infections, but ongoing efforts to reduce catheter use and misuse haven't succeeded as much as health care workers would like.
An international collaboration of infectious disease experts has identified a large group of people who appear to have naturally mounted an immune response to TB, a bacterial infection that is the leading cause of infectious disease death worldwide.
The Association for the Health Care Environment (AHE), of the American Hospital Association, announces the recipient of the 2019 AHE Innovation Award.
Eliminating Trachoma: WHO Announces Sustained Progress With Hundreds of Millions of People No Longer at Risk of Infection
The number of people at risk of trachoma –- the world’s leading infectious cause of blindness –- has fallen from 1.5 billion in 2002 to just over 142 million in 2019, a reduction of 91 percent, the World Health Organization (WHO) has reported.
Respiratory syncytial virus (RSV) and other viruses now appear to be the main causes of severe childhood pneumonia in low- and middle-income countries, highlighting the need for vaccines against these pathogens, according to a study from a consortium of scientists from around the world, led by a
Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitoes. This can lead to innovative and environmentally friendly approaches to reduce malaria.
Scientists have finally found malaria's Achilles' heel, a neurotoxin that isn't harmful to any living thing except Anopheles mosquitoes that spread malaria.
Researchers have now developed a new vaccine, a native outer membrane vesicle (NOMV) vaccine, for meningitis and bloodstream infections caused by "meningococcal group B" bacteria. This will allow younger people to be vaccinated and will address several limitations of the current vaccinations.
The Centers for Disease Control and Prevention (CDC), public health and regulatory officials in several states, and the U.S.